Besides, Wang et al. [38] observed that androgen receptor (AR) could directly bind to the GLUT1 gene promoter to promote GLUT1 transcription, which leading to castration resistance and enzalutamide resistance in prostate cancers. The gene discussed is SLC2A1; the disease is Familial prostate cancer.